Friday, August 17, 2018
Company News: Page (1) of 1 - 02/13/18 Email this story to a friend. email article Print this page (Article printing at page facebook
Worldwide Malocclusion Market Growth at a CAGR of 7.0% till 2023

(February 13, 2018)

"Malocclusion Market"
Market Research Future has a cooked research report on the malocclusion market. Malocclusion: Rising Prevalence of Malocclusion is Likely to Boost The Market Growth at a CAGR of 7.0% During The Forecast Period, 2017-2023

Malocclusion is the misalignment of teeth. Malocclusion is most often hereditary, but it can also occur due to other reasons i.e. childhood habits such as thumb sucking, pacifier use beyond age 3, and others, extra teeth or lost teeth, ill-fitting dental fillings, and jaw tumors. There are three major classes of malocclusion i.e. Class 1, Class 2, and Class 3.

Increasing prevalence of malocclusion, favorable reimbursement scenario, and rising trend of cosmetic dentistry are the key factors driving the malocclusion market.

However, lack of technological awareness and complications associated with malocclusion treatment may hinder the growth of the market to an extent. The lack of technological awareness is mainly attributed to the slow adoption rate of new technology by the dentists.

Get a sample report at .

Key Players in the Malocclusion Market

Some of key the players in the malocclusion market are 3M, A-dec Inc., Adenta GmbH, Align Technology, Inc, American Orthodontics, Biolase, Inc., Carestream Health, Inc., Danaher, DENTAURUM GmbH & Co. KG, Dentsply Sirona, G&H Orthodontics, Henry Schein, Inc., Midmark Corp., Patterson Companies, Inc., Planmeca OY, Rocky Mountain Orthodontics, Septodont Holding, TP Orthodontics, Inc, Ultradent Products Inc., Zimmer Dental Inc., and others.

Regional Analysis

The Americas dominate the malocclusion market owing to the improvement in reimbursement scenario, high healthcare expenditure, and the presence of the leading players in the region. According to the American Dental Association, in the United States, Maryland, Utah, Arkansas, and Massachusetts have the highest Medicaid FFS reimbursement rates i.e. 79.3%, 75.3%, 75.2%, and 74.1% respectively, whereas, Wisconsin, California, Washington, Maine, and Iowa have the lowest coverage relative to private dental insurance reimbursement rates.

Europe holds the second position in the malocclusion market. It is expected that the support provided by the government bodies for research & development, increasing healthcare expenditure, and rising prevalence of malocclusion are propelling the growth of the malocclusion market in the European region. According to the data suggested by Eurostat, it is observed that among the EU Member States, the highest value of healthcare expenditure was recorded in Germany in 2014 i.e. EUR 321 billion which is further followed by France with EUR 237 billion and then United Kingdom with EUR 223 billion.

Asia Pacific region is projected to be the fastest growing region during the forecast period. Rapidly improving technology and the presence of huge patient pool drive the growth of this market in Asia Pacific region.

The Middle East and Africa hold the least share of the malocclusion market owing to the presence of poor and slow developing countries, especially, in the African region.

Browse Complete Report at .

Malocclusion refers to the misalignment of teeth that can lead to serious oral health complications. Malocclusion is commonly hereditary, but it can also occur due to other reasons i.e. childhood habits such as thumb sucking, pacifier use beyond age 3, extra teeth or lost teeth, ill-fitting dental fillings, and jaw tumors. There are three major manifestations of malocclusion i.e. Class 1, Class 2, and Class 3. Class 1 malocclusion is the most common among all types. Treatment for malocclusion depends upon the severity of the condition. Treatment of malocclusion generally includes removal of teeth to correct overcrowding, braces to correct the position of the teeth, wires or plates to stabilize the jaw bone, reshaping, bonding, or capping of teeth, and surgery to reshape or shorten the jaw.

It is noted that rising prevalence of malocclusion is the key factors driving the malocclusion market. According to a study published in International Journal of Environmental Research and Public Health in 2017, it was found that prevalence of malocclusion in Shanghai is 83.9%. It is also reported that the prevalence of deep overbite was the highest in children with malocclusion i.e. 63.7%.

Improvement in reimbursement scenario, and the rising trend of cosmetic dentistry are also fuelling the market growth. The techniques used for the repairing various irregularities such as discoloration, chipped teeth, and misshapen teeth or missing teeth are greatly impacting the growth of the market.

However, lack of technological awareness, and slow adoption rate in low-income countries may strongly hinder the growth of the market.

Media Contact

Company Name: Market Research FutureContact Person: Akash Anand

Email: [email protected]
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune -
City: Pune
State: Maharashtra
Country: India


Page: 1

Related Keywords:Business,Europe,Health & Medicine,U.S,World,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

  • Neurovascular Devices Market High Revenue at USD 24,650 mn by 2023 | Therapeutic Application Hemorrhagic & Ischemic Strokes | Worldwide Segmentation by MRFR
  • The Alzheimer's Research and Prevention Foundation (ARPF) Announces Second Brain Longevity® Therapy Training Program in Washington D.C.
  • Image Guided Radiotherapy Market to Experience Unfaltering Growth at 15.8% CAGR to Revolutionize the Healthcare Sector by 2023
  • Disposable Negative Pressure Wound Therapy Devices Market: Global Industry Analysis (2012 - 2016) & Opportunity Assessment (2017 - 2027)
  • Elysium Health™ Announces Exclusive License for Use of Nicotinamide Riboside for the Slowing of Aging and Prevention of Age-Related Diseases from Mayo Clinic and Harvard

  • Biotest AG: Cytotect(R) CP prevents transmission of Cytomegalovirus (CMV) to the unborn baby in pregnant women who are infected with CMV for the first time
  • Mirati Therapeutics Announces Presentation Of KRAS G12C Chemistry Advances At The 255th American Chemical Society (ACS) National Meeting And Exposition
  • Agenus Receives Second Milestone Payment from Merck
  • Colorado Pain Care Broadens Practice to Include Cancer Patient Treatment in Denver, CO and Surrounding Area
  • Citius Pharmaceuticals Successfully Raises $10 Million

    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines